Nautilus Biotechnology, Inc.
NAUT
$0.791
$0.05156.96%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/4/2025
-
MarketBeat
4/2/2025
-
Ticker Report
3/22/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/4/2025
-
TipRanks Financial Blog
2/28/2025
-
TipRanks Financial Blog
2/28/2025
-
The Fly
2/28/2025
-
Seeking Alpha: Transcripts
2/28/2025
-
SeekingAlpha
2/28/2025
-
Ticker Report
2/28/2025
-
SeekingAlpha
2/28/2025
-
GuruFocus
2/28/2025
-
GuruFocus
2/28/2025
-
TipRanks Financial Blog
2/27/2025
-
GeekWire
2/27/2025
-
TipRanks Financial Blog
2/27/2025
-
The Fly
2/27/2025
-
GuruFocus
2/27/2025
-
Globe Newswire
2/20/2025
-
MarketBeat
2/18/2025
-
GuruFocus
2/18/2025
-
Globe Newswire
2/13/2025
-
MarketBeat
2/13/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
End of April (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
206 333 2001
Address
2701 Eastlake Avenue East
Seattle, WA 98102
Seattle, WA 98102
Country
Year Founded
Business Description
Sector
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company...
more
